What is Veracyte's EV / EBITDA?

Veracyte (VCYT) reported EV / EBITDA of 23.6× in Q1 2026.

How has Veracyte's EV / EBITDA changed year-over-year?

Veracyte's EV / EBITDA decreased by 49.1% year-over-year, from 46.3× to 23.6×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Veracyte VCYT EV / EBITDA

EV / EBITDA at other companies

RevvityRVTY

16.7×-2.2×

Labcorp HoldingsLH

13.3×-1.4×

Quest DiagnosticsDGX

12.6×-0.6×

Agilent TechnologiesA

18.8×-0.5×

Idexx LaboratoriesIDXX

28.9×+1.9×

DanaherDHR

20.5×-2.1×

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.28B+10.7%

Enterprise value$4.05B+7.4%

P/E48.6×-68.3×

P/S7.9×-0.4×

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

enterprise value/ebitda=23.6×

Based on the most recent quarter.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's EV / EBITDA?: Veracyte (VCYT) reported EV / EBITDA of 23.6× in Q1 2026.
How has Veracyte's EV / EBITDA changed year-over-year?: Veracyte's EV / EBITDA decreased by 49.1% year-over-year, from 46.3× to 23.6×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.